- Home
- Beyond the Abstracts
- Urologic Oncology
- Bladder Cancer
Bladder Cancer
A Care Bundle to Improve Perioperative Mitomycin Use in Non-Muscle-Invasive Bladder Cancer – Beyond the Abstract
April 16, 2018
Pseudoprogression Manifesting as Recurrent Ascites with Anti-PD-1 Immunotherapy in Urothelial Bladder Cancer - Beyond the Abstract
April 10, 2018
Omics Strategies Coupled to Imaging Modalities as a Toolbox in Urothelial Cancer – Beyond the Abstract
April 9, 2018
Recommendations for Follow-up of Muscle-Invasive Bladder Cancer Patients: Beyond the Abstract
March 26, 2018
Can re-cTURBT be Useful in pT1HG Disease as a Risk Indicator of Recurrence and Progression? - Beyond the Abstract
March 13, 2018
Urinary Tract Infections Following Radical Cystectomy and Urinary Diversion - Beyond the Abstract
February 14, 2018
Complete Responders to Neoadjuvant Chemotherapy May Not Need Cystectomy - Beyond the Abstract
January 4, 2018
Continent Cutaneous Diversion- Beyond the Abstract
December 4, 2017
Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria - Beyond the Abstract
November 27, 2017
Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy: Beyond the Abstract
November 9, 2017
National Practice Patterns and Outcomes for T4b Urothelial Cancer of the Bladder: Beyond the Abstract
October 24, 2017
Chronic Urinary Retention after Radical Cystectomy and Orthotopic Neobladder in Women: Risk Factors and Relation to Time: Beyond the Abstract
September 19, 2017